Amrapali Capital reports Q2 FY27 un-audited financial results

Amrapali Capital and Finance Services Limited has announced the outcome of its Board Meeting held on November 5, 2026. The board considered and approved the un-audited financial results of the company for the second quarter and half year ended September 30, 2026. This disclosure aligns with SEBI’s Listing Obligations and Disclosure Requirements, providing stakeholders with timely financial performance updates.

Amrapali Capital Board Approves Un-audited Financial Results

Amrapali Capital and Finance Services Limited convened a Board Meeting on November 5, 2026. During this meeting, the board reviewed and approved the un-audited financial results for the half year ended September 30, 2026, which also encompasses the financial performance for the second quarter of the current financial year, 2026-27.

Key Financial Disclosures

The approved un-audited financial results, along with the Limited Review Report, were presented and ratified by the board. This submission is in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 05:35 p.m. and concluded by 05:50 p.m. on the same day.

Financial Snapshot (Half Year Ended September 30, 2026)

The accompanying financial statements reveal a Profit/(Loss) from ordinary activities of ₹267.05 Lakhs for the half-year ended September 30, 2026. This compares to a profit of ₹441.39 Lakhs for the same period in the previous year. Earnings per share (EPS) for the continuing and discontinuing operations stood at ₹2.73 (basic and diluted) for the half-year ended September 30, 2026, against ₹4.51 in the prior year.

Balance Sheet Highlights (As at September 30, 2026)

The total equity and liabilities as of September 30, 2026, were ₹52,728.92 Lakhs. Shareholder funds amounted to ₹9,138.79 Lakhs, with reserves and surplus at ₹8,160.93 Lakhs. Total assets stood at ₹52,728.92 Lakhs, with current assets comprising ₹47,275.63 Lakhs. Notably, inventories stood at ₹18,749.43 Lakhs, and cash and cash equivalents were ₹11,435.87 Lakhs.

Cash Flow Statement Insights (Half Year Ended September 30, 2026)

The cash flow statement indicates a net increase in cash and cash equivalents of ₹337.75 Lakhs for the half-year ended September 30, 2026. Cash flow from operating activities resulted in a net cash usage of ₹38,107.68 Lakhs, while investing activities used ₹168.13 Lakhs. Financing activities generated ₹38,613.56 Lakhs. The closing balance of cash and cash equivalents was ₹1,079.65 Lakhs.

Source: BSE

Previous Article

Dr Agarwal's Health Care issues corrigendum to financial results